Add BrightSurf on Google Email

World Journal of Gastroenterology


Can EUS elastography help distinguish benign from malignant tissue?

A multicenter study found EUS elastography to be highly sensitive and specific in distinguishing benign from malignant tissue, with a sensitivity of 92.3% for pancreatic lesions and 91.8% for lymph nodes. The technique may help characterize pancreatic masses after negative EUS-FNA and increase the yield of EUS-FNA for lymph nodes.

SourceWorld Journal of Gastroenterology·JournalWorld Journal of Gastroenterology·DateApr 15, 2009

The clinical availability of CT colonography

A study published in the World Journal of Gastroenterology found that CT colonography detected extracolonic lesions in 57.8% of subjects, with highly significant lesions present in 8.7% and low significant lesions in 55.2%. Factors such as age, sex, symptoms, and contrast use were associated with detection of more significant lesions.

SourceWorld Journal of Gastroenterology·JournalWorld Journal of Gastroenterology·DateMar 30, 2009

A new molecular marker of gastric cancer

Researchers found that phosphatase regenerating liver 3 (PRL-3) is a new independent prognostic indicator for gastric cancer, predicting tumor recurrence and survival rates. Positive PRL-3 expression was associated with advanced TNM stages, lymph node metastasis, and poorer overall survival rates.

SourceWorld Journal of Gastroenterology·JournalWorld Journal of Gastroenterology·DateMar 30, 2009

Automatic slicing system: Ex-vivo culture normal and cancerous pancreatic tissue

Researchers have developed an automatic slicing system to culture normal and cancerous pancreatic tissue from patient specimens, allowing for reproducible testing of novel treatment options, including gene therapy. This new ex-vivo model assesses cellular heterogeneity and extracellular matrix accumulation in human tumors.

SourceWorld Journal of Gastroenterology·JournalWorld Journal of Gastroenterology·DateMar 24, 2009

RNA interference toward MMP-2 may be an effective therapeutic strategy for cancer

Researchers used RNA interference to suppress MMP-2 expression in pancreatic cancer cells, leading to reduced adhesion and invasion without affecting cell proliferation and apoptosis. This finding suggests that inhibiting MMP-2 via RNA interference could be an effective therapeutic strategy for managing pancreatic tumors.

SourceWorld Journal of Gastroenterology·JournalWorld Journal of Gastroenterology·DateMar 7, 2009

A safe, well-tolerated, and effective treatment for metastatic esophageal cancer

Researchers found that oxaliplatin combined with capecitabine provided a safe, well-tolerated, and effective treatment for patients with metastatic esophageal squamous cell cancer. The combination showed significant clinical benefits, including partial responses in 43.8% of patients and a median overall survival of 10.0 months.

SourceWorld Journal of Gastroenterology·JournalWorld Journal of Gastroenterology·DateFeb 21, 2009

Is it effective of low-dose furazolidone-based quadruple regimens for H pylori infection?

A study published in the World Journal of Gastroenterology found that low-dose furazolidone-based quadruple regimens are effective for treating H pylori infection, with eradication rates ranging from 70-90%. The regimens have a low cost and relatively minor side effects, making them a useful option for rescue therapy, particularly in d...

SourceWorld Journal of Gastroenterology·JournalWorld Journal of Gastroenterology·DateFeb 21, 2009